Navigation Links
JCI online early table of contents: Feb. 7, 2008
Date:2/7/2008

ce they trafficked normally unless the mice were administered an inflammatory stimulus that induced a tissue to express the molecule (known as an antigen) that the T cells recognized. Under these conditions, the T cells from mice expressing an inactive form of PI3K p110-delta failed to migrate and to accumulate in the antigenic tissue, meaning that an immune response was not mounted. Consistent with this, normal T cells treated with a drug that inhibits PI3K p110-delta did not migrate to antigenic tissues activated by an inflammatory stimulus. The authors therefore suggested that drugs inhibiting PI3K p110-delta might be useful in preventing unwanted T cell accumulation in tissues, such as occurs in some autoimmune diseases and inflammatory disorders.

TITLE: T cell receptorinduced phosphoinositide-3-kinase p110-delta activity is required for T cell localization to antigenic tissue in mice

AUTHOR CONTACT:
Federica Marelli-Berg
Imperial College London, Hammersmith Hospital Campus, London, United Kingdom.
Phone: 44-0-2083831704; Fax: 44-0-2083832788; E-mail: f.marelli@imperial.ac.uk.

View the PDF of this article at: https://www.the-jci.org/article.php?id=33267


GASTROENTEROLOGY: The soluble factor IL-10 has guts

Although it is known that the soluble factor IL-10 has an important role in preventing inflammation in the intestine of mice, the function of IL-10 in the human intestine is not well understood. By studying explant cultures of human colonic mucosa (the lining of the large intestine), Anne Jarry and colleague,s at INSERM U539, France, have now shown that IL-10 prevents a damaging inflammatory response being induced by bacteria living naturally in the human colon.

IL-10 was found to be constitutively expressed and secreted by human colonic mucosa. Depletion of IL-10 in explan
'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. HIV denialists spread misinformation online -- consequences could be deadly; and more
2. Consequences of online HIV denial; and more
3. Online Epidemic Gives Clues to Bird Flu Spread
4. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
5. Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding
6. Syndicom to Launch Online Community for DePuy Spine
7. Elder Caregiving Site ShirleyBOARD.com Wins WebAward for Outstanding Online Community
8. Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning
9. CIGNA Behavioral Health Offers Members Online Provider Profiles
10. Dynamic Energy Systems Goes Online and On-Demand
11. North Shore-LIJ Health System Begins Online Posting of Hospital Infection Rates, Other Performance Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... users in Russia might contribute to HIV transmission ... by researchers from Boston University Schools of Medicine ... Pavlov State University, sought to discover the effect ... a cohort of HIV-positive people with lifetime of ... by police were more likely to share needlesincreasing ...
(Date:7/9/2014)... July 9, 2014 There has been a sharp ... Southwestern Medical Center using MyChart, the online, interactive service ... communicate with their healthcare providers, schedule appointments, and renew ... patients actively using MyChart each year increased ... increased more than 10-fold, according to a study by ...
(Date:7/9/2014)... flatulence and have a reputation for being highly toxic, but ... now being being found to offer potential health benefits in ... and dementia. A new compound (AP39), designed and made at ... therapies, by targeting delivery of very small amounts of the ... , Scientists in Exeter have already found that the compound ...
(Date:7/9/2014)... prescription labels handed out by pharmacists may be ... medication, according to new research by the University ... the Blind)., The study, published recently in the ... on prescription medications dispensed by pharmacies do not ... By simply following recommended guidelines for font size, ...
(Date:7/9/2014)... has risen dramatically in Western societies. One frequently cited ... and have fewer infections than previous generations, thereby delaying ... researchers at Sahlgrenska Academy, University of Gothenburg, monitored children ... the immune system in relation to allergic disease. All ... Vstra Gtaland Region, half of them on farms that ...
Breaking Medicine News(10 mins):Health News:BU researchers relate arrests with HIV risk environment 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... 2008 -- Women born after 1944 began drinking alcohol at ... put them at greater risk for alcoholism, according to researchers ... On average, women born before 1944 began drinking at age ... 17, and they had a 50 to 80 percent greater ...
... and ... Launch in Spanish, CHICAGO and ... in health education, and Merck & Co.,Inc., a global research-driven pharmaceutical ... multi-year relationship,to transform how healthcare professionals engage patients in learning about,diabetes ...
... June 5 Nuvelo, Inc.,(Nasdaq: NUVO ) ... the,company,s Wnt Therapeutics program showing that the R-spondin ... pathway that is critical for,cell growth and differentiation ... the activity of Wnt proteins, and,modulated the Wnt ...
... FALLS CHURCH, Va., June 5 CSC (NYSE: ... LLC (DVC), a CSC company, has been,notified by ... funding for,advanced development of plague vaccine will be ... Project Manager Chemical, Biological and,Medical Systems, Joint Vaccine ...
... of alcohol a week can trim that risk by 50%, ... who drink alcohol regularly may cut their risk of developing ... been shown to reduce the risk of cardiovascular disease, and ... risk of rheumatoid arthritis by up to 50 percent. This ...
... LEAN CUISINE(R) are Nutritious and Delicious, SOLON, Ohio, ... know they,re good for us and want to reap ... how to incorporate them into,convenient and tasty meals. A ... benefits of the Omega-3 fatty acids DHA and,EPA. These ...
Cached Medicine News:Health News:Initiating drinking at younger age heightens women's risk for alcohol dependence 2Health News:Initiating drinking at younger age heightens women's risk for alcohol dependence 3Health News:Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U.S. 2Health News:Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U.S. 3Health News:Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U.S. 4Health News:Nuvelo Announces Publication of Preclinical Data From Wnt Therapeutics Program 2Health News:Nuvelo Announces Publication of Preclinical Data From Wnt Therapeutics Program 3Health News:CSC's DynPort Vaccine Company to Continue Plague Vaccine Development 2Health News:CSC's DynPort Vaccine Company to Continue Plague Vaccine Development 3Health News:Drinking Cuts Rheumatoid Arthritis Risk 2Health News:Drinking Cuts Rheumatoid Arthritis Risk 3Health News:Now You Can Have Your Fish and Enjoy It Too... 2Health News:Now You Can Have Your Fish and Enjoy It Too... 3
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... leading,developer of medical simulation systems, today announced an agreement ... and related,products. , Johnson & ... and,is one of the subsidiaries of Johnson & Johnson. ... will have exclusive rights to distribute,Simbionix,s line of advanced ...
... Newly Diagnosed Patients Receive a Drug Within One Year ... from Decision ResourcesWALTHAM, Mass., April 15 /PRNewswire/ ... leading research and advisory firms focusing on pharmaceutical and ... than 30 percent of their use of emerging oral ...
Cached Medicine Technology:Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries 2Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line 2Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line 3
AccuSign® DOA Series Opiates Test...
... The SureStep™ Drug Screen Tests are ... assay for MDMA (Ecstasy). Designed using Microgenics ... is the only point of care immunoassay ... affinity for both MDA and MDEA but ...
The SEDITAINER Erythrocyte Sedimentation Rate (ESR) System is for collection of blood specimens for the measurement of ESR within the blood collection tube, using the SEDITAINER ESR Stand....
... NMP22® Test Kit is a quantitative microplate enzyme ... are at risk for rapid recurrence or occult ... voided urine sample and is twice as sensitive ... to improve patient outcome by identifying those patients ...
Medicine Products: